According to a new report from Intel Market Research, the global Gene Expression Assay Service market was valued at USD 555 million in 2024 and is projected to reach USD 810 million by 2031, growing at a steady CAGR of 5.6% during the forecast period (2024–2031). This growth trajectory stems from escalating demand for precision medicine, advancements in genomics research, and the increasing need for biomarker discovery across therapeutic areas.
Gene expression assay services provide researchers with critical tools to measure mRNA transcript activity, enabling breakthroughs in understanding disease mechanisms and therapeutic targets. These services have become indispensable for pharmaceutical R&D, academic research, and clinical diagnostics.
Download FREE Sample Report:
Gene Expression Assay Service Market – View in Detailed Research Report
Key Market Technologies
The market encompasses several established and emerging technologies:
-
Real-time qPCR – Remains the workhorse for targeted expression analysis due to its cost-effectiveness and reliability
-
Digital PCR – Gains traction for absolute quantification needs with outstanding precision
-
RNA-Seq – The fastest-growing segment, enabling comprehensive transcriptome analysis
Leading companies like Thermo Fisher Scientific and Bio-Rad Laboratories continue enhancing their platforms, with 2024 seeing significant improvements in throughput and data analysis capabilities.
Market Drivers
1. Pharmaceutical Outsourcing Trend Accelerates
The pharmaceutical industry’s shift toward outsourcing specialized services has become a major growth driver. With over 65% of preclinical programs now incorporating gene expression analysis and outsourcing rates increasing by 22% annually, service providers are expanding capacities to meet demand. This trend reflects pharma’s strategic focus on leveraging external expertise for complex genomic analyses.
2. Precision Medicine Initiatives Fuel Adoption
National precision medicine programs worldwide are driving unprecedented demand for gene expression profiling. The U.S. All of Us program, UK Biobank, and China’s 14th Five-Year Plan are creating large-scale genomic datasets requiring specialized analysis services—positioning gene expression assays as foundational tools in personalized healthcare.
Emerging Applications
While traditional research applications dominate current usage, several emerging areas show strong potential:
-
Liquid Biopsies – Circulating RNA analysis for non-invasive cancer monitoring
-
Single-cell Analysis – Unlocking cellular heterogeneity in tumor microenvironments
-
Spatial Transcriptomics – Mapping gene expression within tissue architecture
These advanced applications are expected to drive the next wave of market expansion as technologies mature.
Competitive Landscape
The market features a mix of established players and specialized service providers:
-
Thermo Fisher Scientific – Market leader with comprehensive qPCR and NGS solutions
-
Bio-Rad Laboratories – Strong in digital PCR applications
-
Charles River Laboratories – Expanding functional genomics services
Smaller firms like Fios Genomics and Avance Biosciences are carving niches through specialized bioinformatics integration and AI-enhanced analysis.
Regional Insights
-
North America leads in market share (38%) due to strong R&D infrastructure and pharma concentration
-
Asia-Pacific shows fastest growth, fueled by increasing research investment and outsourcing
-
Europe maintains steady demand through academic and clinical research initiatives
Service providers are strategically expanding in emerging markets to capitalize on growing local biotech sectors.
Market Challenges
Despite strong growth prospects, the industry faces hurdles:
-
Sample Quality – RNA degradation remains a persistent challenge affecting data quality
-
Data Analysis Complexity – Requires specialized bioinformatics expertise that many labs lack
-
Standardization Issues – Variability across platforms complicates cross-study comparisons
Service providers addressing these challenges through robust quality systems and integrated analysis solutions are best positioned for success.
Future Outlook
The convergence of several trends points to sustained market expansion:
-
Continued pharma R&D investment in targeted therapies
-
Expansion of clinical applications for gene expression analysis
-
Technological advances reducing costs and improving accessibility
Get Full Report Here:
Gene Expression Assay Service Market – View in Detailed Research Report
About Intel Market Research
Intel Market Research is a leading provider of strategic intelligence, offering actionable insights in biotechnology, pharmaceuticals, and healthcare infrastructure. Our research capabilities include:
-
Real-time competitive benchmarking
-
Global clinical trial pipeline monitoring
-
Country-specific regulatory and pricing analysis
-
Over 500+ healthcare reports annually
Trusted by Fortune 500 companies, our insights empower decision-makers to drive innovation with confidence.
Website: https://www.intelmarketresearch.com
International: +1 (332) 2424 294
Asia-Pacific: +91 9169164321
LinkedIn: Follow Us
